Professionals 310 results
Capabilities 63 results
Industry
Industry
Practice Area
Experience 66 results
Experience
|April 23, 2025
Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination
Experience
|January 29, 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Experience
|January 24, 2025
Acquisition of Glendale Senior Dining, Inc.
Insights & News 1,987 results
Product Liability & Mass Torts Digest
|September 17, 2025
|4 Min Read
Supreme Court To Settle if All’s Well That Ends Well in Diversity Jurisdiction
The Supreme Court has granted certiorari in Hain Celestial Group, Inc. v. Palmquist to determine whether a final order issued by a federal court may stand if an appellate court later determines the district court erred in dismissing a nondiverse defendant and denying a motion to remand.
Direct Sellers Update: Regulation, Law & Policy
|September 16, 2025
|6 Min Read
The FTC Trades Blanket Non-Compete Bans for Case-by-Case Enforcement
Direct Sellers, time to let out a sigh of relief. On September 5, 2025, the Federal Trade Commission officially dropped its appeal of a federal court’s decision striking down the FTC’s rule banning non-competes.
Capital Markets & Securities Law Watch
|September 16, 2025
|7 Min Read
The FCA’s New Prospectus Rules: A Bold Reset for UK Capital Markets
On 15 July 2025, the Financial Conduct Authority (FCA) released Policy Statement PS25/9, confirming the final rules under the Public Offers and Admission to Trading Regulations 2024 (POATRs). These reforms overhaul the UK’s prospectus regime, replacing the retained EU Prospectus Regulation and taking effect from 19 January 2026. The new framework aims to simplify capital raising, reduce costs for issuers and enhance the UK’s competitiveness as a listing venue.
The FCA’s reforms are part of a broader government strategy to ensure regulation is targeted, proportionate and growth-oriented. They follow extensive consultation, including CP24/12 and CP25/2, and reflect recommendations from Lord Hill’s UK Listing Review and the Secondary Capital Raising Review.
Other Results 64 results
Law Glossary
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?
Law Glossary